Colorectal Neoplasms: all 5,738 studies
Page 47 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.CompletedNCT01691391
- A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)CompletedNCT01689792Phase 4
- The Magnitude of Effect of PCP Counseling on Participation Rate and Sedation Rate in Colonoscopy-based Screening ProgramCompletedNCT01688817Not applicable
- The Immunoscore as a Prognostic Marker for Patients With a Colorectal CancerStatus unknownNCT01688232
- INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for CancerStatus unknownNCT01679756Not applicable
- Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerStatus unknownNCT01679327Phase 2
- Intra-arterial Hepatic Bevacizumab and Systemic ChemotherapyCompletedNCT01677884Phase 2
- An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)CompletedNCT01676922
- Psychological Well-being Outcomes in Disease-free Survivors of Colorectal Cancer Following Curative SurgeryStatus unknownNCT01675505
- An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)CompletedNCT01674907
- Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal CancerStatus unknownNCT01673607Phase 2
- Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)CompletedNCT01671592Phase 1
- Hatha Yoga for Patients With Colorectal CancerCompletedNCT01669109Not applicable
- Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTerminatedNCT01668680Phase 2
- Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal CancerCompletedNCT01668498Phase 2
- Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality IndicatorsCompletedNCT01667198Not applicable
- Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant NeoplasmCompletedNCT01657773
- European Physician Survey of EGFR Inhibitor Prescribing PatternsCompletedNCT01652833
- Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)CompletedNCT01652482Phase 2
- Supportive Cancer Care Networkers (SCAN)CompletedNCT01651832Not applicable
- Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence DistrictCompletedNCT01651624Not applicable
- Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-RasStatus unknownNCT01651013
- Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesWithdrawnNCT01646554Phase 2/3
- Pharmacology-driven Dosing of Fluoropyrimidines in Cancer PatientsCompletedNCT01641458Phase 4
- Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsCompletedNCT01640522Not applicable
- Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)CompletedNCT01640444Phase 2
- Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral CellsCompletedNCT01640405Phase 3
- Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1Status unknownNCT01639326Phase 2
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer ScreeningCompletedNCT01634126Early Phase 1
- Water Exchange Versus Carbon Dioxide for ColonoscopyCompletedNCT01633333Not applicable
- Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsCompletedNCT01632722Phase 2
- Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRCWithdrawnNCT01631539Not applicable
- Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study)CompletedNCT01629524
- Increasing Uptake of Colorectal Cancer Screening in OntarioCompletedNCT01629004Not applicable
- Colonic Stent and Tumor Cell DisseminationCompletedNCT01628328
- Second Look Laparoscopy in Colorectal CancerStatus unknownNCT01628211Phase 2
- Single-port Versus Conventional Laparoscopic Colorectal SurgeryStatus unknownNCT01626963Phase 1/2
- Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal BleedingCompletedNCT01623206Phase 2
- I-Scan Versus High-definition White LightCompletedNCT01617278Not applicable
- Evaluating Coaches of Older Adults for Cancer Care and Health BehaviorsCompletedNCT01613430Not applicable
- Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue DietStatus unknownNCT01610895Not applicable
- Impact of Probiotics on the Intestinal MicrobiotaCompletedNCT01609660Phase 4
- Benefit of Rehabilitation Program in Colorectal SurgeryCompletedNCT01609361Not applicable
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)CompletedNCT01609075
- The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal CancerCompletedNCT01606098Phase 3
- Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal CancerTerminatedNCT01605318Phase 1/2
- Serum Proteomic Profiling for the Early Diagnosis of Colorectal CancerCompletedNCT01604798
- Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsCompletedNCT01604564
- Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingCompletedNCT01600209
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal CancerCompletedNCT01596790Not applicable
- Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based ChemotherapyCompletedNCT01596634Not applicable
- Verification of a Pharmacogenetic Approach to Customizing Chemotherapy to AsiansStatus unknownNCT01596361
- Exploration the Effect of Walking Program in Patients With Colorectal CancerCompletedNCT01595256Not applicable
- Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal CancerCompletedNCT01591590Not applicable
- P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.CompletedNCT01591421Phase 1/2
- A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF TherapyCompletedNCT01591109
- Identification the Expression of Sox2 in Colorectal Cancer TissuesCompletedNCT01589900
- ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.Status unknownNCT01589146Phase 3
- Double-balloon Colonoscopy to Increase Colonoscopy Completion RateTerminatedNCT01587872Not applicable
- Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyCompletedNCT01584830Phase 3
- Head to Head Study Epi proColon and FITCompletedNCT01580540
- Pharmacokinetics and Metabolic Activation of CapecitabineCompletedNCT01579357Phase 2
- Invasiveness and Chemoresistance of Cancer Stem Cells in Colon CancerCompletedNCT01577511
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal CancerCompletedNCT01575340Not applicable
- Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical TestWithdrawnNCT01574677
- Efficacy of Vitamin D in Colorectal Cancer ChemopreventionCompletedNCT01574027Phase 2
- BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerCompletedNCT01571024Phase 1
- Matrilysin Expression in Different Stages of Colorectal TumorsCompletedNCT01570452
- The Norwegian Dietary Guidelines and Colorectal Cancer Survival StudyActive, not recruitingNCT01570010Not applicable
- Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver MetastasisCompletedNCT01569984Phase 2
- Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary CareCompletedNCT01569620Not applicable
- Testing Interventions to Motivate and EducateCompletedNCT01568151Not applicable
- Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal CancerStatus unknownNCT01567917
- FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal CancerStatus unknownNCT01566942Phase 3
- Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver MetastasisCompletedNCT01565811
- Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal CancerStatus unknownNCT01564810Phase 4
- Online Study of Colorectal Cancer and Prostate Cancer Screening Decision MakingCompletedNCT01558583Not applicable
- Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk PopulationCompletedNCT01557101Phase 4
- Performance Evaluation of the NaviAid™ G-Eye SystemCompletedNCT01552200Not applicable
- Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal CancerCompletedNCT01550055Phase 2/3
- The Effect of a Virtual Navigator on Colorectal Cancer Patient EmpowermentCompletedNCT01549327Not applicable
- The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation SurveyStatus unknownNCT01549067
- Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to FluoropyrimidinesTerminatedNCT01547923Not applicable
- Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for CancerStatus unknownNCT01542281Not applicable
- Combined Anticancer Treatment of Advanced Colon CancerTerminatedNCT01540344Phase 2
- Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard TherapyNo longer availableNCT01538680
- Pilot Study of a National Screening Programme for Bowel Cancer in NorwayActive, not recruitingNCT01538550Not applicable
- Doctor-Patient Communication About Colorectal Cancer ScreeningCompletedNCT01534923
- Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer PatientsCompletedNCT01533740
- Prevalence and Characteristics of Nonpolypoid Colorectal Neoplasms - A Chinese Cohort StudyCompletedNCT01533311
- 2nd-line Treatment of Metastatic Colorectal CancerTerminatedNCT01532804Phase 2
- Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal CancerCompletedNCT01531777Phase 2
- Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal CancerActive, not recruitingNCT01531595Phase 2
- Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2
- Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via ColonoscopyCompletedNCT01526239Not applicable
- PillCam Colon Capsule and CT-colonography in the Evaluation of Patients With Incomplete Conventional ColonoscopyCompletedNCT01525940Not applicable
- A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated SteatosisTerminatedNCT01523639Phase 2